3
Announcements
Trials
Browse
Landscape
Phase
Phase 2
1
Status
Unknown
1
Sponsor Class
OTHER
1
Study Type
Interventional
1
Sponsor
Cancer Type
Lymphoid
1
Conditions
Leukemia
48
Precursor Cell Lymphoblastic Leukemia-Lymphoma
40
Lymphoma
40
Myelodysplastic Syndromes
30
Lymphoma, Non-Hodgkin
29
Lymphoma, Large B-Cell, Diffuse
27
Lymphoma, Follicular
27
Leukemia, Myeloid, Acute
26
Leukemia, Myeloid, Chronic-Phase
25
Leukemia, Lymphocytic, Chronic, B-Cell
24
Burkitt Lymphoma
24
Leukemia, Myeloid, Accelerated Phase
23
Lymphoma, Large-Cell, Immunoblastic
22
Multiple Myeloma
20
Hodgkin Disease
20
Myeloproliferative Disorders
19
Lymphoma, Mantle-Cell
18
Lymphoma, B-Cell, Marginal Zone
18
Graft vs Host Disease
18
Blast Crisis
18
Neoplasms, Plasma Cell
17
Leukemia, Myelomonocytic, Chronic
16
Dendritic Cell Sarcoma, Interdigitating
15
Leukemia, Myeloid, Chronic, Atypical, BCR-ABL Negative
14
Congenital Abnormalities
14
Recurrence
13
Anemia, Refractory, with Excess of Blasts
13
Primary Myelofibrosis
12
Myelodysplastic-Myeloproliferative Diseases
12
Lymphoma, T-Cell, Cutaneous
10
Interventions
Cyclophosphamide
26
fludarabine
16
Etoposide
15
Melphalan
13
romidepsin
12
Gemcitabine
11
Whole-Body Irradiation
10
Vincristine
10
Peripheral Blood Stem Cell Transplantation
10
Doxorubicin
10
fludarabine phosphate
9
Rituximab
9
Lenalidomide
9
Cytarabine
9
Busulfan
9
pembrolizumab
8
Prednisone
8
Mycophenolic Acid
8
Granulocyte Colony-Stimulating Factor
8
Bortezomib
8
Filgrastim
7
Carmustine
7
Brentuximab Vedotin
7
Biopsy
7
duvelisib
6
Tacrolimus
6
Specimen Handling
6
Dexamethasone
6
Bendamustine Hydrochloride
6
ruxolitinib
5
Date Range
30 days
90 days
1 year
All
Options
Has results
Has announcements
Clinical Trials
1 trials
Recent
Start date
Enrollment
OTHER
×
Lymphoma, T-Cell
×
Methylprednisolone
×
Clear all
NCT01719835
2018-03-15
CHEMO-T
Royal Marsden NHS Foundation Trust
Phase 2
Unknown
87 enrolled